Basel Medical Group Ltd Ordinary Shares
BMGL | NASDAQ
$5.11
+$0.07 (+1.39%)
At close: Nov 2, 2026, 4:00 PM ET
$5.00
-$0.04 (-0.79%)
Pre-market:
Nov 2, 2026, 9:25 AM ET
TTM Period Ending | Q2 2025 Dec 31, 2025 | Q4 2024 Jun 30, 2025 |
|---|---|---|
Revenue | 14.29M | 6.05M |
Cost of Revenue | 14.63M | 5.41M |
Gross Profit | -339K | 644.32K |
Operating Income | -4.53M | -1.61M |
Interest Income | 31.86K | 26.01K |
Pretax Income | -10.01M | -10.34M |
Net Income | -9.67M | -9.94M |
Selling & General & Admin | 4.19M | 2.26M |
Research & Development | n/a | n/a |
Other Expenses | n/a | n/a |
Operating Expenses | 4.19M | 2.26M |
Interest Expense | 317.49K | 102.42K |
Selling & Marketing Expenses | n/a | n/a |
Cost & Expenses | 18.82M | 7.67M |
Income Tax Expense | -227.11K | -402.41K |
Shares Outstanding (Basic) | 1.57M | 18.79M |
Shares Outstanding (Diluted) | 1.57M | 18.79M |
EPS (Basic) | -0.35 | -0.52 |
EPS (Diluted) | -0.35 | -0.52 |
EBITDA | -1.68M | -815.39K |
EBIT | -4.53M | -1.61M |
Depreciation & Amortization | 2.85M | 799.14K |
Add to Watchlist
Select watchlists to add or remove BMGL